Your browser doesn't support javascript.
loading
Durable remissions in a pivotal phase 2 study of brentuximab vedotin in relapsed or refractory Hodgkin lymphoma.
Gopal, Ajay K; Chen, Robert; Smith, Scott E; Ansell, Stephen M; Rosenblatt, Joseph D; Savage, Kerry J; Connors, Joseph M; Engert, Andreas; Larsen, Emily K; Chi, Xuedong; Sievers, Eric L; Younes, Anas.
Afiliação
  • Gopal AK; University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA;
  • Chen R; City of Hope National Medical Center, Duarte, CA;
  • Smith SE; Loyola University Medical Center, Maywood, IL;
  • Ansell SM; Mayo Clinic, Rochester, MN;
  • Rosenblatt JD; University of Miami Sylvester Comprehensive Cancer Center, Miami, FL;
  • Savage KJ; British Columbia Cancer Agency Center for Lymphoid Cancer, Vancouver, BC, Canada;
  • Connors JM; British Columbia Cancer Agency Center for Lymphoid Cancer, Vancouver, BC, Canada;
  • Engert A; University Hospital of Cologne, Cologne, Germany;
  • Larsen EK; Seattle Genetics, Inc., Bothell, WA;
  • Chi X; Takeda Pharmaceuticals International Company, Cambridge, MA; and.
  • Sievers EL; Seattle Genetics, Inc., Bothell, WA;
  • Younes A; Memorial Sloan Kettering Cancer Center, New York, NY.
Blood ; 125(8): 1236-43, 2015 Feb 19.
Article em En | MEDLINE | ID: mdl-25533035
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article